-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B0Uiq2Js0HP9xUzvImqGOdRnPH+3qznL6a2+Qek6B8/PZNuzzroq2DezujYWq7Zl IBb1iL7Y410fjM4zQ3vKtg== 0001193125-03-004604.txt : 20030513 0001193125-03-004604.hdr.sgml : 20030513 20030513113349 ACCESSION NUMBER: 0001193125-03-004604 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030513 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMPAC MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0001026448 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 943109238 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50082 FILM NUMBER: 03694424 BUSINESS ADDRESS: STREET 1: 100 W EVELYN AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 BUSINESS PHONE: 6506238800 MAIL ADDRESS: STREET 1: 100 W EVELYN AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 8-K 1 d8k.htm FORM 8-K DATED MAY 13, 2003 Form 8-K dated May 13, 2003

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported)

  

May 13, 2003


 

IMPAC Medical Systems, Inc.


(Exact name of registrant as specified in its charter)

 

Delaware

    

000-50082

    

94-3109238


(State or other jurisdiction
of incorporation)

    

(Commission File
Number)

    

(IRS Employer
Identification No.)

100 West Evelyn Avenue, Mountain View, CA

    

94041


(Address of principal executive offices)

    

(Zip Code)

 

Registrant’s telephone number, including area code

  

(650) 623-8800


 

 

 


(Former name or former address if changed since last report)


 

Item 5.    Other Events.

 

On May 13, 2003, IMPAC Medical Systems, Inc. (the “Company”) issued a press release announcing the public offering of 2,378,223 shares of its common stock. A copy of this press release is attached hereto as Exhibit 99.1.

 

Item 7.    Financial Statements and Exhibits.

 

(c)    Exhibits.

 

99.1    IMPAC Medical Systems, Inc. Press Release dated May 13, 2003.

 

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

IMPAC MEDICAL SYSTEMS, INC.

By:

 

/s/  Joseph K. Jachinowski        


   

Joseph K. Jachinowski
President and Chief Executive Officer

 

Date: May 13, 2003

 

 

 

3


EXHIBIT INDEX

 

Exhibit No.


  

Description


99.1

  

IMPAC Medical Systems, Inc. Press Release dated May 13, 2003.

EX-99.1 3 dex991.htm PRESS RELEASE DATED MAY 13, 2003 Press Release dated May 13, 2003

Exhibit 99.1

 

FOR IMMEDIATE RELEASE

 

Contact:

Dorian Momsen

IMPAC Medical Systems, Inc.

650-623-8800

 

IMPAC MEDICAL SYSTEMS, INC.

PRICES FOLLOW-ON PUBLIC OFFERING

AT $19.00 PER SHARE

 

MOUNTAIN VIEW, Calif., May 13, 2003 – IMPAC Medical Systems, Inc. (Nasdaq: IMPC) announced today the public offering of 2,378,223 shares of its common stock at $19.00 per share. Of the total, 200,000 shares were offered by IMPAC and 2,178,223 shares were offered by selling stockholders. IMPAC will not receive any of the proceeds from the sale of the shares by selling stockholders. Proceeds received by IMPAC from the sale of 200,000 shares will be used for working capital.

 

Thomas Weisel Partners LLC acted as lead manager and U.S. Bancorp Piper Jaffray and William Blair & Company, L.L.C. acted as co-managers of the underwriting group. The underwriters have a 30-day option to purchase up to 356,733 additional shares of common stock from certain stockholders to cover over-allotments, if any.

 

IMPAC Medical Systems, Inc. is a leading provider of information technology systems for cancer care. IMPAC’s products provide an integrated clinical and administrative solution to manage the complexities of cancer care, from detection and diagnosis through treatment and follow-up. Specializing in the development of practice management, electronic medical record, image management and decision support software, IMPAC offers practical solutions that help healthcare providers better manage the process of delivering care.

 

Copies of the prospectus may be obtained from: Thomas Weisel Partners LLC, One Montgomery Street, San Francisco, CA 94104.

 

#    #    #

-----END PRIVACY-ENHANCED MESSAGE-----